about
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney DiseaseMitochondria: a new therapeutic target in chronic kidney diseaseSystemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitorsPersonalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicineDownregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patientsMitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patientsKaryopherins: potential biological elements involved in the delayed graft function in renal transplant recipients.NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center.Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.mTOR inhibitors and renal allograft: Yin and Yang.Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells.Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase.Dialysis-related transcriptomic profiling: the pivotal role of heparanase.Dialysis-related systemic microinflammation is associated with specific genomic patterns.In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets.Sclerostin and Dickkopf-1 in Post-menopausal Renal Allograft Recipients
P50
Q26740125-86289AF5-2168-4718-B7F2-5D1EDDFBD6C6Q26776397-63210ED9-90FA-4179-AF96-3AB420AF350FQ26823023-A7350C6E-22C6-46E4-AF7F-E6CD49FDD2A6Q28082746-51A26D99-93EC-4B59-BD90-62CE743B712BQ28534658-73B2CE01-0F96-4855-9EEF-E8DC84D3416BQ33495688-BF9DF0D1-1B44-4173-B943-B6D6106A0398Q34714685-F154D9D8-2415-464A-974F-DAF7CE4CE219Q35119530-BE9CC444-426F-4DCF-B898-4D3F8523BB42Q35208558-73F5444C-B0A6-4E5B-9EB9-7158D5BC2A79Q35497673-6F2AFD5B-F33F-403A-9608-ACD132689D04Q37646842-39B7057E-4551-4072-89BD-0E01EA716E28Q38209973-E9E2D75B-9201-4989-8AA3-856538756262Q38866153-E5F6113A-73AA-4CE4-9B92-5E960EC6A1A7Q39060681-5868610A-177D-4C4F-BB77-93FDBF1261EFQ39321185-B63EB108-8FB0-4E25-A4D8-1D4DD2104CA9Q40148485-F2C11DD0-3D1A-4906-ADED-E5BCC1A85486Q52314292-80A7D53C-78E5-4717-BFA5-48B68D79E1F7Q59419742-8903BAC2-3E27-43B5-83F3-C49EC37EC9FB
P50
description
researcher ORCID ID = 0000-0002-3740-7598
@en
wetenschapper
@nl
name
Simona Granata
@ast
Simona Granata
@en
Simona Granata
@es
Simona Granata
@nl
type
label
Simona Granata
@ast
Simona Granata
@en
Simona Granata
@es
Simona Granata
@nl
prefLabel
Simona Granata
@ast
Simona Granata
@en
Simona Granata
@es
Simona Granata
@nl
P106
P1153
24334781700
P21
P31
P496
0000-0002-3740-7598